Andrew Pitts - May 2, 2025 Biohaven secures $600M investment to advance life-changing therapies, including for spinocerebellar ataxia We extend a big congratulations to our client, Biohaven Ltd., on recently entering into an ...
Thomas Wolter - July 22, 2024 UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step 2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent ...
Eliot Ward - October 4, 2023 UPC at four months old - a review The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...
Julie Carlisle - August 10, 2023 Mewburn Ellis team up with Support Dogs to sponsor an Assistance Dog This week (7 – 13 August 2023) is International Assistance Dog Week and this year we're excited to ...
Thomas Wolter - July 6, 2023 Beating the Punch: UPC Protective Letters The Unified Patent Court (UPC) is now operational. As of June 1, 2023, patentees can enforce ...
Thomas Wolter - November 21, 2022 Plausibility and Inventive Step at the EPO - Watch G2/21 live on Thursday 24 November On Thursday 24 November 2022, the Enlarged Board of Appeal (EBA) will hear the parties in case ...
Thomas Wolter - June 27, 2022 EPO presses pause on proceedings that depend on the plausibility referral to the EBA Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Thomas Wolter - April 27, 2022 Plausibility strikes again – BMS blockbuster apixaban patent found invalid by UK High Court In a recent judgment the UK High Court of Justice revoked European Patent (UK) 1 427 415 B1 and a ...
Maria Hall - February 3, 2020 Munich office expansion with high-profile lateral hire We are delighted to announce the high-profile appointment of Dr. Thomas Wolter into our Munich ...
